Mirati Therapeutics reported $52K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Amgen AMGN:US $ 31989M 112M
Astellas Pharma 4503:JP Y 103001M 0M
AstraZeneca AZN:LN 387M 59M
Bayer BAYN:GR € 2515M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Bristol Myers Squibb BMY:US $ 292M 0M
Eisai 4523:JP Y 44986M 0M
Eli Lilly And LLY:US $ 598.2M 0.1M
Exelixis EXEL:US $ 0.32M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 901M 12M
Puma Biotechnology PBYI:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.16M 0M
Takeda 4502:JP Y 1676263M 7138M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
YTE INCY:US $ 0.22M 0M